TYK Medicines, Inc. Class H (2410) Stock Statistics & Valuation Metrics

TYK Medicines, Inc. Class H has a market cap or net worth of HK$1.34B. The enterprise value is HK$2.11B.

TYK Medicines, Inc. Class H has 380,065,830 shares outstanding. The number of shares has decreased by -2.65% in one year.

TYK Medicines, Inc. Class H’s return on equity (ROE) is -1.02 and return on invested capital (ROIC) is -50.58%.

The current PE Ratio of TYK Medicines, Inc. Class H is ―. TYK Medicines, Inc. Class H’s PEG ratio is 0.47.

In the last 12 months, TYK Medicines, Inc. Class H had revenue of 0.00 and earned -292.01M in profits. Earnings per share was -0.78.

In the last 12 months, operating cash flow was -212.86M and capital expenditures -56.10M, giving a free cash flow of -268.96M billion.

TYK Medicines, Inc. Class H pays an annual dividend of ―, resulting in a dividend yield of ―

TYK Medicines, Inc. Class H upcoming earnings date is Apr 1, 2027, Before Open (Confirmed).

TYK Medicines, Inc. Class H as a current ratio of 1.43, with Debt / Equity ratio of 57.34%

In the past 12 months, TYK Medicines, Inc. Class H has paid 0.00 in taxes.

TYK Medicines, Inc. Class H EV to EBITDA ratio is -14.51, with an EV/FCF ratio of -16.44.

TYK Medicines, Inc. Class H has HK$201.96M in cash and marketable securities with HK$149.63M in debt, giving a net cash position of HK$52.33M billion.

Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.

The average price target for TYK Medicines, Inc. Class H is ―, which is 11.43% higher than the current price. The consensus rating is ―